Sirnaomics Ltd. (HKG:2257)
Hong Kong · Delayed Price · Currency is HKD 5.29
-0.63 (-10.64%)
Jun 1, 2026, 3:58 PM HKT
Sirnaomics Employees
Sirnaomics had 37 employees as of December 31, 2025. The number of employees decreased by 32 or -46.38% compared to the previous year.
Employees
37
Change
-32
Growth
-46.38%
Revenue / Employee
n/a
Profits / Employee
-3.03M HKD
Market Cap
576.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 37 | -32 | -46.38% | 37 | 0 |
| Jun 30, 2025 | 52 | - | - | 52 | 0 |
| Dec 31, 2024 | 69 | -76 | -52.41% | 69 | 0 |
| Dec 31, 2023 | 145 | -80 | -35.56% | 145 | 0 |
| Dec 31, 2022 | 225 | 50 | 28.57% | 222 | 3 |
| Dec 31, 2021 | 175 | 18 | 11.46% | 175 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 543 |
| JW (Cayman) Therapeutics Co. | 292 |
| Immunotech Biopharm | 183 |
| Transcenta Holding | 171 |
| 3D Medicines | 162 |
| Sunho Biologics | 128 |
| Kintor Pharmaceutical | 123 |
| Wuhan YZY Biopharma | 106 |
Sirnaomics News
- 2 months ago - Sirnaomics Earnings release: H2 2025 - Filings
- 2 months ago - Sirnaomics Annual report: H2 2025 - Filings
- 9 months ago - Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Benzinga
- 9 months ago - Sirnaomics Quarterly report: H1 2025 - Filings
- 9 months ago - Sirnaomics Earnings release: H1 2025 - Filings